Chemung Financial Corp (CHMG) · Oct 22, 2026 · Earnings
Beat — EPS $2.63 vs published consensus ~$1.95
Chemung Financial’s Q3 earnings beat expectations, with commercial lending and funding-cost control boosting core income despite rising nonperforming loans.
Chemung Financial is expanding beyond its Southern Tier base by building commercial lending in the Albany and Buffalo markets, using prior balance-sheet restructuring to redirect capital toward loans.
| Metric | Q3 2026 | Comparison |
|---|---|---|
| Diluted EPS | $2.63 | $1.62 in Q3 2025; published consensus ~$1.95 |
| Net income | $12.7M | $7.8M in Q3 2025 |
| Net interest income | $25.7M | +13.2% year over year |
| Fully taxable equivalent NIM | 3.74% | 3.45% in Q3 2025 |
| PPNR | $13.9M | $11.1M in Q3 2025 |
| Commercial loan balances | $1.886B | $1.671B in Q3 2025 |
| Nonperforming loans | $13.8M / 0.57% | $7.9M / 0.35% at Dec. 31, 2025 |
| Quarterly dividend | $0.36/share | Up from $0.34 |
The earnings beat is real, but not entirely recurring. EPS of $2.63 substantially exceeded the published consensus of roughly $1.95, while net interest income rose 13.2% and pre-provision net revenue rose 24.9% year over year. The quarter also benefited from a $2.9 million recovery tied to a settled commercial-loan litigation matter, which turned credit-loss expense into a $2.6 million benefit rather than a provision.
The core banking engine improved as expected, with better-than-expected magnitude. Commercial loan growth, lower deposit costs, and the deployment of excess cash into loans lifted the net interest margin to 3.74% from 3.45% a year earlier. Average commercial loan balances rose $221.1 million year over year, while the cost of interest-bearing liabilities fell to 2.30% from 2.51%. That supports the strategy already visible in prior quarters, but the quarter shows the benefit flowing more clearly into earnings. 〔0〕
Credit quality is the main offset to the strong income statement. Nonperforming loans increased to $13.8 million, or 0.57% of loans, from $7.9 million, or 0.35%, at year-end, with new problem credits concentrated in commercial and commercial-real-estate lending. The allowance ratio also slipped to 1.05% of loans from 1.07%, and coverage of nonperforming loans fell to 183% from 306%. The litigation recovery flatters this quarter’s credit results, so the underlying test is whether new commercial problem loans stabilize.
The charter conversion and planned unified branding are strategic housekeeping, not the quarter’s main signal. The national-bank conversion was completed October 1, 2026, and the Canal Bank & Trust rollout is planned for 2027. The dividend increase to $0.36 per share adds a modest shareholder-return signal, but the earnings and credit trends matter substantially more.
Bottom line: This was a clear earnings beat with genuine improvement in the core lending and funding model, amplified by a one-time litigation recovery. The business is executing its commercial-growth strategy, but rising commercial nonperforming loans keep the quarter from being an unqualified read-through.
Canal Bank & Trust rebrand rollout beginning 2027
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!